Keith A. Reynolds

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

After a 5-year trial, the company is ending its entry into health care, citing the lack of a "sustainable business model."

Cabotegravir extended-release injectable suspension is the first injectable PrEP to receive FDA approval and is given only every 2 months.

Two-day business training filled with tips for physicians.

AAFP, citing the increased health threat posed by the SARS-CoV-2 Delta variant, is calling on the FDA to expand current EUA to include patients younger than 12 years.

The NIAID head said the timing of the end of the pandemic is really up to the public.

In the open letter to HHS secretary Azar, the American Hospital Association urges him to be more transparent about the vaccine rollout.

CEOs of 9 drug companies involved in COVID-19 vaccine development signed a pledge ensuring that sound science and ethics will guide the process.

The American College of Physicians' position paper on ethical and professional use of electronic communications comes at the perfect time.

A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.